Quantitative & Derivatives Strategy
The J.P. Morgan View : Market pushes ahead with volatility low and froth building
March 6, 2024
The J.P. Morgan View : Market pushes ahead with volatility low and froth building
The J.P. Morgan View : Market pushes ahead with volatility low and froth building
This document is being provided for the exclusive use of blake@sandboxfp.com.
06 March 2024

Update (first published 04 March 2024) (See disclosures for details)

This material is neither intended to be distributed to Mainland China investors nor to provide securities investment consultancy services within the territory of Mainland China. This material or any portion hereof may not be reprinted, sold or redistributed without the written consent of J.P. Morgan.

The J.P. Morgan View

Market pushes ahead with volatility low and froth building

J.P. Morgan does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision.

YTD returns by asset

Source: J.P. Morgan.

Cross-Asset Strategy: Equities have moved up this year, even as bond yields rose and rate cut expectations unwound. Investors may be assuming that the increase in yields is reflective of economic acceleration, but earnings projections for 2024 are coming down and the market appears too complacent on the cycle. With yields close to 2M highs, neutral positioning, and softer data expected in the coming week, we recommend adding duration in 5Y USTs and hold 5s/30s steepeners. We expect the ECB to remain firmly in data-watching mode at its March meeting, so we keep strategic longs in 5Y Germany but add 3s/10s EUR swap curve bear flatteners. US HG bond spreads remained in a tight range in February, with spreads tighter despite record issuance for the month, another reflection that supply follows demand. Euro HG spreads are likely to trade range-bound due to excess corporate cash balances being depleted, M&A activity picking up, and higher reverse Yankee issuance. In HY and LL, February registered a post-pandemic high in defaults. The most disruptive outcome for FX would be a hawkish Fed repricing, which as in 2023 would likely result in broad USD strength. But, unlike 2023, higher US yields should not automatically also result in positive returns from carry given thinner yield cushions. We expect a contraction in global gasoline demand in 2025 (the first on record, outside of recession) due to the shift to EVs and efficiency gains.

JPM Clients’ View: Click here to take this week’s survey. This week we poll investors on China, Bitcoin, the BoE and BoJ, in addition to our running sentiment questions. Our last survey results indicated: (1) equity exposure/sentiment among respondents is ~52nd percentile on average; (2) 32% planned to increase equity exposure, and 76% to increase bond duration near-term; (3) 60% believe the Feb CPI release is more likely to surprise to the upside than downside; (4) 79% see NVDA as overvalued, though only 28% believe it’s in a bubble; (5) respondents were close to evenly split both on whether Chinese equities are at a positive inflection point and whether the BoJ will exit negative rates in March.

Market pushes ahead with volatility low and froth building: Stocks continuing to push to new record highs and Bitcoin surging over $60k may indicate accumulating froth in the market. This may keep monetary policy higher for longer, as premature rate cutting risks further inflating asset prices or causing another leg up in inflation. We see a dichotomy in volatility markets: stock vol is near multi-year lows despite expensive valuations/elevated positioning/high concentration, rates vol remains stubbornly high given uncertainty around the timing/pace of rate cuts, and yet FX volatility has moved sharply lower despite elevated rates levels and vols.

New Trades: Initiated Jun25/Jun26 Euribor conditional bull steepener via 1Y and 2Y mid-curve calls, 10s/15s German steepeners (Bassi); bought worst-of calls on SPX, SX5E, NKY and KO calls/call ratios on SX5E (Silvestrini).

Upcoming Catalysts: Fed member speeches (all week); ECB meeting, US trade balance, Japan BoP (3/7); US payrolls, Euro GDP & China CPI/PPI (3/8).

Cross-Asset Strategy

Economics

Current-quarter growth looks stronger and more broadly based. Activity indicators are consistent with a moderation in GDP growth from its strong 2H23 pace, but have been firmer than we expected. As a result, our global growth forecasts are rising alongside the current-quarter data flow—continuing the general pattern of recent quarters. Together with solid US performance, the global economy is turning into the new year with greater balance, a point underscored by the February manufacturing PMI survey. The output survey took a significant step up in the first two months of the year and now aligns with our forecast for roughly 2%ar factory output growth in 1H24. It is encouraging to see a rebound in the orders/inventory ratio and the capital goods PMI, which lifts our CapexNow tracking for global equipment spending.

An expected rebound in US and Euro area core service price inflation. We maintained conviction that a sharp 2H23 slide in global core goods price inflation was ending while a material disinflation in services prices was unlikely this year. A wide array of global indicators pointed to fading goods deflation, whereas macroeconomic fundamentals—tight labor markets, elevated labor cost gains, and still-solid services demand gave us confidence that services prices would remain sticky. This mix of an end to goods price deflation and still elevated service price gains is on track to deliver core inflation at roughly 3%ar in both economies in 1H24. Our top-down views of resilience and sticky inflation appear inconsistent with the roughly 150bp easing currently priced for Fed and the ECB over 2024-25.

Looking for more fiscal ease in China. Policy supports in China are building as fiscal initiatives have been accompanied by a large ongoing injection of liquidity. We believe more will be needed to reach the 2024 growth target of ~5% and look to this week’s NPC for signs of what comes next. We expect the central government deficit target to be raised to 3.8% of GDP. The impact of this impulse on the economy will likely be tempered as local government sources of funding remain constrained. A key concern about policy support to date has been its bias toward increasing productive capacity rather than consumer demand. This resulted in a buildup of inventories pushing down domestic and export prices. Any sign of a shift in focus would be constructive (GDW, Mar 1st).

Equities

2024 EPS projections keep coming down. Why didn’t equities weaken as US 10Y yields backed up 50bp YTD? We think this is because investors assumed that the yields up-move is reflective of economic acceleration, but we note that earnings projections for 2024 are not reacting positively and the market is now too complacent on the cycle. In terms of drivers: 1) US activity momentum is expected to be sequentially weaker, in 0-1% real GDP growth range by mid-year. Labor markets remain a bright spot, but that can change quickly, and retail sales momentum is waning. 2) Repricing of Fed futures higher in the past weeks might not be just due to better growth outlook, but also more persistent inflation. 3) Profit margins are softening, topline growth is weakening, net interest expense is set to move back up, and ULCs could start increasing. 4) At 21x, US forward P/E is very stretched, especially vs real yields. 5) Sentiment and positioning indicators are near highs (Equity Strategy: March Chartbook, Mar 4th).

Nikkei 225 tops bubble era high. The end of 3 decades of deflation that began with the bubble’s collapse kicked off the current bull market. The bubble era high symbolizes Japan’s “lost three decades,” so the new high is being seen as highly significant, impacting sentiment for corporate managers and Japanese people as a whole. We also think this will spur corporates to increase growth investment and improve capital efficiency, and make investors take more interest in Japanese stock investing (Japan Equity Strategy, Feb 27th). We see don’t see signs that Japanese stocks are overheated, in particular from a longer-term perspective, and in index terms we see investment appeal even at current share price levels. Japanese corporate earnings rose on the whole in the Oct–Dec quarter, and the balance between profit growth and valuation multiples is not distorted in contrast to the bubble economy era (Japan Equity Strategy, Mar 3rd).

Bonds

Bond yields retraced some of the rise in the previous weeks, but remain elevated. With yields close to 2-month highs, markets pricing in a later start to easing and fewer cuts than we expect, our Treasury Client Survey continuing to point to an elevated share of neutrals and as we see softer-than-expected data in the coming week, we recommend adding duration in 5Y USTs. We also hold 5s/30s steepeners as a medium-term expression of our Fed view and as we see higher term premia over time given the rising share of price sensitive investors.

In the Euro area, a smaller-than-expected decline in CPI supports recent pushback from ECB speakers on near-term easing expectations, and we expect the ECB to remain firmly in data-watching mode at its March meeting. We keep strategic longs in 5Y Germany but add 3s/10s EUR swap curve bear flatteners as a tactical hedge. In the UK, we see little impact from the likely modest fiscal measures in the Spring budget. We hold tactical Aug24/Nov24 MPC OIS flatteners and Mar24/Sep24 SONIA futures curve flatteners.

Our EM client survey showed a slight reduction in already relatively modest net EM local duration longs, while longs in EM hard currency sovereigns rose to their highest level since Feb’23. We stay OW local bond duration, with OWs in Brazil, Colombia, Uruguay, Czechia, Poland, South Africa and Indonesia, partially offset by a short duration overlay and an UW in Romania (EM Fixed Income Focus, Feb 15th).

Credit

US HG bond spreads remained in a tight 8bp range in February. In yet another reflection that supply follows demand, spreads are tighter despite record issuance for a February, which is 28% higher than the prior record set just last year. This is notable given that March is typically the busiest supply month of the year. Inflows have not only increased overall this year but are also stronger m/m, unlike last year when inflows tapered off somewhat from Jan to Feb. We continue to see valuations as being expensive but yields remain attractive and risk assets more broadly remain on an uptrend. We also continue to view spreads as expensive here but recognize the risk that they could go tighter still if yields remain supportive and macro concerns continue to dissipate (Credit Market Outlook & Strategy, Mar 1st).

Euro HG spreads will likely trade range bound over the near-term between 130-140bp, in our view. We revise up our full year HG issuance forecast by €35bn to €550bn gross / €80bn net. This is driven by: 1) excess corporate cash balances being depleted; 2) M&A activity picking up; and 3) higher reverse Yankee issuance (European Credit Weekly, Mar 1st).

February registered a post-pandemic high in actual defaults and a 10-month high in volume affected by defaults/distressed transactions in HY and LL. Combined there were 12 defaults/distressed transactions totaling $9.9bn in bonds and loans. The difference between par and issuer-based default rates is the highest on record and underscores the impact distressed exchanges have had on default activity over the last few years. The distressed universe of bonds and loans is at a low since May 2022 (Default Monitor, Mar 1st).

The main narrative at the SFIG conference was that spreads have significantly tightened in mortgage credit and other parts of SPG, but there does not look to be a big catalyst for widening unless Fed expectations are significantly repriced. Investors remain neutral on mortgage credit and saw some value in agency MBS, jumbo 2.0 and non-QM AAA/Mezz. Money managers continue to see inflows and the insurance bid for duration remains strong. Given these dynamics, new issue deals continue to be multiple times oversubscribed. Higher loan size borrowers appear to be driving delinquencies higher in non-QM, which is surprising since a larger loan size is typically an indicator of borrower creditworthiness (RMBS Credit Commentary, Mar 1st).

Currencies

Upcoming US data will set the tone for FX. We consider a broad roadmap for select outcomes. 2023 offers clues given some similarities, but differences will be relevant as well. The most disruptive outcome for FX would be a hawkish Fed repricing, which as in 2023 would result in broad USD strength. Unlike 2023, higher US yields should not automatically also result in positive returns from carry given thinner yield cushions.

Macro Trade Recommendations: Take profit on EUR/SEK cash shorts but stay long SEK vs CZK in cash and EUR in options. Stay modestly long USD vs EUR & CAD via options amid lingering US exceptionalism and prospects of tariffs. Long JPY vs EUR in cash, vs USD and CHF in options. Short EUR/CHF in cash. Stay OW EM FX (FXMW, Mar 1st).

Commodities

Moving along the electrification road. 21.6 million electrified vehicles (BEV, PHEV, hybrids) were likely sold worldwide in 2023 or 33% of total auto sales. The market is moving from early adopters to early mass majority in Europe and China, while the US remains a nascent market. Sales of battery EVs are still rising, but the growth rate appears to be easing, while hybrids emerge as a bridge technology to pure EVs. Fully or partially electric vehicles are now a meaningful share of the fleet, representing about 7% of the global fleet, likely shaving ~500 kbd off global gasoline demand between 2019 and 2023, with 400 kbd of those from the US and China. Increasing pressure from electrification and efficiency gains will likely lead to a first on record, outside of recession, contraction in global gasoline demand in 2025 and a cumulative loss of 0.9 mbd by 2030 (Oil Markets Weekly, Feb 26th).

How much is a deviation from average Chinese seasonal inventory builds worth? Metals demand has been somewhat slow to hit its stride post LNY holiday, though inventories are still showing relatively tame builds, despite higher production in China. Copper stock builds fell back in line with normal seasonality last week while primary aluminum and zinc builds continued to undershoot. This year, copper and zinc prices have outpaced implied performance from seasonal Chinese stock build deviations while aluminum has lagged (Metals Weekly, Mar 1st).

Qatar LNG capitalizes on US policy uncertainty. Qatar announced further expansion of its LNG export capacity by 16 mtpa, just weeks after the Biden administration announced a pause in new LNG project approvals. As the new expansion is projected to come on line by 2030 and with no details known on financing, partnerships or contracting, we expect it to have no to minimal impact on our published global gas balances by 2030 (Global Natural Gas Flash Note, Feb 26th).

JPM Clients’ View

Click here to take this week’s survey

This week, we poll investors on China, Bitcoin, the BoE and BoJ, in addition to our running survey questions on equity positioning/sentiment, and intentions for near-term changes to equity allocation and bond duration. The results from the last survey are shown below.1

Figure 1: What is your current equity positioning or sentiment in historical terms, expressed from most bearish (0th percentile) to most bullish (100th percentile)?

Source: J.P.Morgan

Figure 2: Are you more likely to increase or decrease equity exposure over the coming days/weeks?

Source: J.P. Morgan.

Figure 3: Are you more likely to increase or decrease bond portfolio duration over the coming days/weeks?

Source: J.P. Morgan.

Figure 4: Do you think the February CPI release in mid-March is more likely to surprise to the upside or downside?

Source: J.P. Morgan.

Figure 5: In your view, Nvidia is:

Source: J.P. Morgan.

Figure 6: Are Chinese equities at a positive inflection point?

Source: J.P. Morgan.

Figure 7: Do you expect the BoJ to exit negative rates in March?

Source: J.P. Morgan.

JPM Clients’ View - This Week’s Interim Survey Results

The charts below show interim results from this week’s survey, collected over the first ~24 hours it was live. The survey remains open here, and we will show updated results in the next J.P. Morgan View publication

Figure 8: What is your current equity positioning or sentiment in historical terms, expressed from most bearish (0th percentile) to most bullish (100th percentile)?

Source: J.P.Morgan

Figure 9: Are you more likely to increase or decrease equity exposure over the coming days/weeks?

Source: J.P. Morgan.

Figure 10: Are you more likely to increase or decrease bond portfolio duration over the coming days/weeks?

Source: J.P. Morgan.

Figure 11: Do you expect China growth will surprise to the upside in the first half of this year?

Source: J.P. Morgan.

Figure 12: Does the surge in Bitcoin prices signal broad market frothiness?

Source: J.P. Morgan.

Figure 13: The market is pricing in 27bps of hikes by the BoJ this year – do you expect the BoJ to ultimately deliver more or less hiking than the market expects by year-end?

Source: J.P. Morgan.

Figure 14: Do you believe the BoE will unwind all of its QE portfolio, as Deputy Governor Ramsden suggested it might in remarks last week?

Source: J.P. Morgan.

Market pushes ahead with volatility low and froth building

January PCE came in line with consensus although below our expectations, with m/m for headline PCE at 0.3%, core PCE at 0.4%, and supercore (core ex housing) at 0.6%. Despite the strong January numbers, the year-ago inflation rates are still down from where they were six months prior, pointing to an ongoing moderation in the underlying trend of inflation. The activity data from the report, in particular some improvement on nominal income and employee compensation, led us to revise our 1Q US GDP growth estimate from 1.75% to 2.25% saar. With the PCE print in line with expectations, it produced a muted effect on markets, with long-end yields initially falling slightly only to reverse on weak month-end demand. More recently, Friday’s US data saw declines in consumer sentiment, ISM manufacturing, and construction spending – disappointing relative to consensus, but our economists do not see these results as alarming.

As for what to expect at the upcoming ECB meeting, our economists expect the ECB to remain on hold and maintain a data-dependent approach, as we wait for more clarity on inflation after the upward surprise in core this week as well as labor market developments. We expect the meeting to be mostly uneventful for Euro duration, with markets mostly focusing on the discussion around the new ECB staff projections as the growth and inflation projections likely will be an indicator of the direction of upcoming monetary policy decisions. Despite negative returns YTD, we are expecting an average return of +6.5% across DM bond markets, assuming our 2024 year-end yield targets are realized ( Figure 15).

The earnings season, now almost done in the US, confirmed our expectation discussed in last week’s publication, namely the continued outperformance of US versus Europe, in line with our regional allocation preference. So now with 93% having reported in the US, we have +8% earnings growth y/y, and with 70% reported in Europe, -11% y/y earnings growth, which is sequentially better in the US and worse in Europe. A similar outperformance of US over Europe was seen in earnings beats (+7% US vs -2% Europe) and revenue growth (+4% US vs -6% Europe), although sales beats were better for both. Looking ahead to the full-year 2024 outlook, a much smaller proportion of companies are raising EPS guidance, well below the historical median ( Figure 16).

With stocks at highs, we have described risk assets as priced to perfection, in other words, reflecting little risk to earnings growth, margins, economic growth, etc. Looking at the longer-term history, there is no shortage of periods where stocks stayed overbought for long periods of time, however we feel the current environment continues to leave us vulnerable to an accident. Whereas the earnings growth of the Magnificent 7 has been 56%, the S&P 500 ex Mag7 saw earnings shrink by 2% ( Figure 17). So currently, we have the uncomfortable choice of buying something already expensive albeit with good earnings growth, or something cheap, perhaps justifiably so with negative earnings growth.

When looking for a pullback off highs, it has been useful to get a sense of the froth in markets, and one measure that jumps out is the Bitcoin price at ~$63k. Alternatively, we might consider speculative tech ETFs, many of which have lost 2/3 of their value, but now seem to have bottomed and attempting to stage a comeback. The takeaway from these indicators is that there appears to be room for them to go further before we reach recent extremes of speculative excess, but thinking about how rising asset prices fits into the broader picture of central banks looking to cut rates, the effect is likely to make them even more wary given strong growth and inflation. The worry is that premature rate cutting could feed into inflating asset prices further or cause another leg up in inflation, but if the disinflation is still immaculate, ‘what’s the rush?’, paraphrasing Fed governor Waller.

With stocks at highs and VIX near multi-year lows, we consider whether volatility is generally cheap or not. While our US economics forecasts have us rebounding off Q2-Q3 growth of 0.5%, historically reaching such low levels has been a precursor to further worsening. Given the strong jobs market, cash cushion, US consumers and corporates shielded from rising rates, this time may be different, but we can still consider where vols should be assuming we’re late-cycle. Stock vol has been in the neighborhood of multi-year lows, making us nervous given stocks are expensive (relative to bonds and cash), well-owned, concentrated into megacaps, overly reliant on the AI story, and seemingly assuming zero chance of growth risk (by virtue of being at highs). Rates vol has remained stubbornly high which is logical in DM markets where there has been uncertainty around the timing and amount of rate cutting. In the past few weeks there has been this dichotomy of sharply lower FX volatility despite stubborn rates vols and higher US rates, so it appears that this may provide a decent entry point ( Figure 18). Our FX vs. rates model, after a steady compression over the past few months of 2023, is now seeing FX vols (average USD/G10) cheap by around 2.5-3 vol points ( Figure 19). We offer two general paths to benefit from low FX vols for a) FX carry trades via options and b) for playing hedges against higher rates scenario.

As for China, we look ahead to the upcoming NPC as a guide to the fiscal budget and other policy targets. We expect the annual growth target to be unchanged at ‘around 5%’ for 2024, which should be challenging as the uplift from reopening has faded. We expect both fiscal and monetary policy will be more growth-friendly than 2023 but not a ‘bazooka’ style stimulus. It would be a positive surprise if the work report shares the market concerns on economic challenges, such as deflation, unemployment, housing, etc. The budget deficit could be another source of positive surprise, assuming fiscal will contribute more to growth stabilization efforts. China’s February manufacturing PMIs were in-line with expectations with a decent uptick in the NBS non-manufacturing PMIs suggesting near-term growth momentum. Putting together the two pieces, the NBS composite PMI output stayed at 50.9, the highest level since October, suggesting steady economic activity momentum. There remain reasons to be cautious, with the employment component of PMI looking subdued, suggesting weak labor market will be a drag on household sentiment. Softness in pricing power and deflation generally should continue to hurt corporate profit, restraining the private investment outlook. And the housing market activity continues to be sluggish. Meanwhile, Chinese equities are still trading below our bearish target for the 2024, while buybacks rose 3.3-fold y-y in the first two months of the year. With Korean and Japanese regulators pushing for corporate governance reforms in favor of shareholder returns, China has followed suit with a new reform-minded CSRC Chairman, lifting hopes for more follow-throughs including China’s version of a comprehensive corporate governance reform scheme. Notably, Chinese listcos have substantially raised share buybacks YTD. MXCN constituents listed in A-share/HK that report buybacks on a high-frequency basis repurchased US$4.9bn in shares over 2M24, more than tripling (3.3x) the first two-month average of US$1.5bn over 2021-23.

With the global PMIs coming out, we revisit how the recent dislocations in the asset classes are shaping up. The ongoing theme is markets ‘priced to perfection’, looking expensive but not yet at the extremes we’ve seen in other late-cycle periods. Apart from the dislocation with the PMIs, there is the ongoing disconnect between earnings yields and bond yields, with tight risk premia arguing for conservative allocations. The combination of a good US earnings season and better than expected economic growth data, has for many justified the continued rally, but the flip side is that if the January strength persists, pushing back the start of cutting keeps us ‘high for long’, which should pose a strain on margins. Mitigating this is the unprecedented situation of rates going up, while company interest expense has gone down (thanks to borrowing at low fixed rates, while cash balances are earning more), which is the example of how the transmission of monetary policy tightness is blunted at least in the US. Of course, narrowly focusing on the disconnect with the PMIs can be misleading as Japan shows up expensive in this comparison vs global composite PMIs which we see as justified given the structural changes there. But the broader point remains of risk assets being overly optimistic relative to PMIs, expensive by about 1 standard deviation according to this simple framework ( Figure 20).

Figure 15: Since the beginning of the year, DM bonds have delivered negative returns across the board, turning positive by 2024 year-end, assuming our targets are achieved

Quarterly breakdown for 2023 and projected return until the end of 2024, %

Source: J.P. Morgan Global Fixed income

Figure 16: % of S&P500 companies guiding EPS higher/lower

Source: : J.P. Morgan Equity Research, Bloomberg Finance L.P.

Figure 17: S&P500 vs S&P500 ex Mag 7 Q4 ‘23 earnings growth

Source: Bloomberg Finance L.P., J.P. Morgan Equity Research

Figure 18: FX vol has moved down sharply especially compared to rates vol

Source: Bloomberg Finance L.P., J.P. Morgan.

Figure 19: FX volatility is now meaningfully cheap for the state of the global business cycle

VXY Global modeled as a function of Global PMI, trailing 12-mo standard deviation of Global PMI and dispersion of consensus US CPI, GDP and unemployment forecasts

Source: Philadelphia Fed, J.P.Morgan Currency Research

Figure 20: Dislocation of risky assets vs Global Composite PMIs

Source: J.P. Morgan, Bloomberg Financial L.P.

Global Research Digest

Macro & Cross-Asset Views

Equity Strategy: Three key drivers of to date resilient corporate profitability to turn weaker, Mislav Matejka, CFA

Corporate profit margins are elevated in a historical context and appear to be peaking out. We see 3 sources of downside to profit margins and to earnings from here: Many corporates benefitted from the unique feature of this cycle – as interest rates increased 300bp+, the net interest expense came down; top line was exceptionally strong post COVID for many corporates, as pricing power was high; and if the economy slows, partly because the supports that it enjoyed last year do not repeat, such as fiscal stimulus, ULCs could pick up. Profit margin proxy, corporate deflator minus ULCs, could turn into more of a headwind.

The Long-term Strategist: Climate and extreme weather risk is not priced into US residential real estate, Alexander Wise

Despite record-high damages from extreme weather events, we see little impact on US home prices at the county level. Since 2000, homes in counties in the top quintile of climate and extreme weather risk have risen ~40% more in price than they did on average across all other counties. This is consistent with other evidence that Americans have moved on net towards areas with higher risk of extreme weather, instead of away from them. We show that population growth was higher on average in more exposed counties. While rising property insurance costs could force homeowners to focus on climate and extreme weather risk, it is unclear that property insurance prices have risen yet in line with risk. 

Flows & Liquidity: How low are equity yields?, Nikolaos Panigirtzoglou

Risk premia have compressed significantly over the past few months. Our long-term fair value model suggests the equity discount rate is at a similar level to the 2007 market peak and not far from levels at the 2000 peak. And the slope of the risk-return trade-off line, or the “expected Sharpe Ratio”, is currently at similar levels to its lows in 1989, 1998 and 2007. We estimate the potential equity selling by quarter-end due to rebalancing by US defined benefit pension funds and Norges Bank/GPIF/SNB could be up to $120bn with a similar amount of bond buying.

Global Economics and the Recovery from COVID-19

DM easing: the whole is greater than the sum of the parts, Bruce Kasman

Consensus expectations for a substantial easing cycle ahead have remained firmly in place, however, with market pricing incorporating a roughly 150bp decline in policy rates for the Fed, ECB, and BoE by the end of next year. Two related arguments have reinforced expectations for a substantial policy easing over 2024-25 absent a slide into recession. First, the inflation surge of 2021-23 that prompted an unprecedented, synchronized DM policy tightening is fading fast as negative supply shocks related to the pandemic and Russia’s invasion of Ukraine have been removed from the scene. Second, neutral real policy rates were pushed significantly lower over the past decade and, as a result, the current stance of monetary policy is materially restrictive.

Global Inflation Monitor: January 2024 – Sticky around 3%, Nora Szentivanyi

Recognizing the elevated noise in the January data, particularly in the US, we highlight two signals in the global CPI data. First, core goods prices ex. US autos rose 0.16% m/m in January, a firming that aligns with global developments pointing to an end of global goods price deflation in 1H24. Second, the 0.5% m/m rise in service prices, boosted by a 0.7% jump in the US, likely exaggerates underlying trends but points to continued stickiness in service price inflation. We see global core inflation (ex-China and Türkiye) ticking higher to 3.3% in 1Q24 before easing to 2.8% in 2Q24.

A preview of the NPC, Haibin Zhu

We expect the NPC will keep its annual growth target unchanged at “around 5%” in 2024, which will be a challenging task as the reopening dividend has largely faded. To achieve the target, we have argued that both fiscal and monetary policy will be more growth-friendly than 2023, but not a “bazooka” style stimulus. On fiscal policy, we look for a 3.8% of GDP budgetary deficit, which could be in the form of 3% official deficit plus 1tn yuan special central government bonds. We also expect the government to reiterate its monetary policy narrative with expanded use of structural monetary policy.

Global Market Implications

Credit Market Outlook & Strategy: Supply is on the March, Eric Beinstein

We continue to see valuations as being expensive but yields remain attractive and risk assets more broadly remain on an uptrend. There seems to be some recent supply indigestion in IG over the past few days with new issue bonds underperforming the overall index by 2bp over the past 10 days versus typical outperformance (~4bp on average since 2015). We believe these are only short-lived effects of the supply surge and should normalize soon as there do not appear to be any real cracks in the demand technicals at this juncture.

Oil Markets Weekly: Moving along the electrification road, Natasha Kaneva

On a global scale, increasing pressure from electrification and efficiency gains should ultimately offset demand increases in emerging markets like India, Africa, and other APAC countries, leading to a contraction in global gasoline demand of 50 kbd in 2025, 100 kbd in 2026 and a cumulative total loss of 0.9 mbd by 2030. Fully or partially electric vehicles represent now 7% of the global fleet, likely shaving almost 500 kbd off global gasoline demand between 2019 and 2023, with 400 kbd of those from the US and China. Sales of battery EVs are still rising, but growth rate appears to be easing, losing market share to hybrids.

Global Natural Gas Flash Note: Qatar LNG capitalizes on US policy uncertainty – neutral impact on global gas balances to 2030, Shikha Chaturvedi

As Qatar’s new LNG expansion is projected to come on line by 2030 and with no details known on financing, partnerships or contracting, we expect it to have no to minimal impact on our published global gas balances by 2030. Our balances implied abundance of supply by 2030, and the announcement adds to potentially oversupplied global gas/LNG market beyond 2030. However, we note potential upside in the longer-term gas demand as countries remain cautious on nuclear growth and LNG remains the major viable option to substitute coal in the power generation mix.

New York Community Bank: With Identified Weaknesses in Controls, a Goodwill Impairment and New CEO Announced, Risk Profile of the Stock Remains Outside of Our Comfort Zone, Steven Alexopoulos, CFA

Following the latest news of NYCB identifying weaknesses in controls related to internal loan review, along with both NYCB’s Chief Risk Officer and Chief Audit Executive recently departing and the bank’s credit ratings agencies taking actions in response to 4Q23 results, the risk profile of this stock remains outside of our comfort zone. Even with shares trading at 0.4x 2024e TBV or at a 62% discount to peers, we see the prudent strategy for investors being to stay on the sidelines and maintain our Neutral rating. We also continue to view the situation at New York Community as being very specific to NYCB and not representative of pressure/uncertainty on regional banks more broadly.

The EM Fixed Income Sustainable Debt Asset Class: Introducing our inaugural publication detailing the EM fixed income sustainable debt asset class, Goulden, Martin Heriz, Harvey, Meyers

The EM fixed income sustainable debt asset class is now $1.1tn in size, making it 11% of the EM hard currency debt stock but only 3% of EM local currency debt. Use-of-proceeds bonds are the largest part of the asset class, with Green bonds dominating at 62% of outstanding notional, Sustainability bonds have 16% of outstanding and Social bonds 10%. We also look at new developments for the EM fixed income sustainable debt asset class, focusing on the emerging themes around biodiversity and adaptation, as well as development finance and impact investing.

Sector-Level Views

US Diversified Biopharma: Key Takeaways from Our US Obesity Survey, Chris Schott, CFA

We recently conducted a survey of 45 US physicians (endocrinologists/diabetologists, cardiologists, and primary care physicians) on their current and expected future GLP-1 use and wanted to share our key takeaways. Respondents see broad use of incretins in both the obese as well as overweight populations with weight-related comorbidities a major factor into their prescribing decision.

EMEA Spotlight: Elections 2024 – Geographical exposure to relevant countries across our EMEA coverage universe, Sophie L Warrick and Bruna Haq

Our EMEA coverage has the highest concentration exposure to Europe, with 179 companies having 60%+ revenue exposure to the region, with Banks making the highest proportion of this (22 companies). Overall, the countries/region where our European coverage has the highest average revenue exposure is to Europe (42%), the UK (22%) and the USA (18%). Meanwhile, Healthcare has the highest average revenue exposure to the US (35%), Financials to the UK (32%) and Europe (51%) and TMT to India (3%).

Asian Tech: Key takeaways from Taiwan CEO-CFO Conference, Gokul Hariharan

Tech demand continues to remain polarized, with all things AI continuing to see strong demand in the near-term and the number of beneficiaries in the AI space starting to broaden out as AI Inference in the Datacenter ramps up and in preparation for bringing AI to the edge. Tech earnings revisions continue to gather momentum and a broadening out of AI beneficiaries is likely to drive an improved breadth of EPS revisions through course of 2024.

Strategy & Forecasts

GAA Long Only Model Portfolio

Equity sector recommendations and YTD returns

Source: J. P. Morgan, Bloomberg Finance L.P.

JPM Forecasts

Source: J.P. Morgan, Bloomberg Finance L.P., Datastream.

  1. 1 Results are based on 44 responses received from clients in our survey conducted Feb 26-Mar 4th

Risks of Common Option Strategies

Risks to Strategies: Not all option strategies are suitable for investors; certain strategies may expose investors to significant potential losses. We have summarized the risks of selected derivative strategies. For additional risk information, please call your sales representative for a copy of “Characteristics and Risks of Standardized Options.” We advise investors to consult their tax advisors and legal counsel about the tax implications of these strategies. Please also refer to option risk disclosure documents.

Put Sale: Investors who sell put options will own the underlying asset if the asset’s price falls below the strike price of the put option. Investors, therefore, will be exposed to any decline in the underlying asset’s price below the strike potentially to zero, and they will not participate in any price appreciation in the underlying asset if the option expires unexercised.

Call Sale: Investors who sell uncovered call options have exposure on the upside that is theoretically unlimited.

Call Overwrite or Buywrite: Investors who sell call options against a long position in the underlying asset give up any appreciation in the underlying asset’s price above the strike price of the call option, and they remain exposed to the downside of the underlying asset in the return for the receipt of the option premium.

Booster : In a sell-off, the maximum realized downside potential of a double-up booster is the net premium paid. In a rally, option losses are potentially unlimited as the investor is net short a call. When overlaid onto a long position in the underlying asset, upside losses are capped (as for a covered call), but downside losses are not.

Collar: Locks in the amount that can be realized at maturity to a range defined by the put and call strike. If the collar is not costless, investors risk losing 100% of the premium paid. Since investors are selling a call option, they give up any price appreciation in the underlying asset above the strike price of the call option.

Call Purchase: Options are a decaying asset, and investors risk losing 100% of the premium paid if the underlying asset’s price is below the strike price of the call option.

Put Purchase: Options are a decaying asset, and investors risk losing 100% of the premium paid if the underlying asset’s price is above the strike price of the put option.

Straddle or Strangle: The seller of a straddle or strangle is exposed to increases in the underlying asset’s price above the call strike and declines in the underlying asset’s price below the put strike. Since exposure on the upside is theoretically unlimited, investors who also own the underlying asset would have limited losses should the underlying asset rally. Covered writers are exposed to declines in the underlying asset position as well as any additional exposure should the underlying asset decline below the strike price of the put option. Having sold a covered call option, the investor gives up all appreciation in the underlying asset above the strike price of the call option.

Put Spread: The buyer of a put spread risks losing 100% of the premium paid. The buyer of higher-ratio put spread has unlimited downside below the lower strike (down to zero), dependent on the number of lower-struck puts sold. The maximum gain is limited to the spread between the two put strikes, when the underlying is at the lower strike. Investors who own the underlying asset will have downside protection between the higher-strike put and the lower-strike put. However, should the underlying asset’s price fall below the strike price of the lower-strike put, investors regain exposure to the underlying asset, and this exposure is multiplied by the number of puts sold.

Call Spread: The buyer risks losing 100% of the premium paid. The gain is limited to the spread between the two strike prices. The seller of a call spread risks losing an amount equal to the spread between the two call strikes less the net premium received. By selling a covered call spread, the investor remains exposed to the downside of the underlying asset and gives up the spread between the two call strikes should the underlying asset rally.

Butterfly Spread: A butterfly spread consists of two spreads established simultaneously – one a bull spread and the other a bear spread. The resulting position is neutral, that is, the investor will profit if the underlying is stable. Butterfly spreads are established at a net debit. The maximum profit will occur at the middle strike price; the maximum loss is the net debit.

Pricing Is Illustrative Only: Prices quoted in the above trade ideas are our estimate of current market levels, and are not indicative trading levels.

Correction: Update: Survey results added on page 5.

Companies Discussed in This Report (all prices in this report as of market close on 05 March 2024, unless otherwise indicated)New York Community Bank(NYCB/$3.22/N)

Disclosures

Analyst Certification: The Research Analyst(s) denoted by an “AC” on the cover of this report certifies (or, where multiple Research Analysts are primarily responsible for this report, the Research Analyst denoted by an “AC” on the cover or within the document individually certifies, with respect to each security or issuer that the Research Analyst covers in this research) that: (1) all of the views expressed in this report accurately reflect the Research Analyst’s personal views about any and all of the subject securities or issuers; and (2) no part of any of the Research Analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed by the Research Analyst(s) in this report. For all Korea-based Research Analysts listed on the front cover, if applicable, they also certify, as per KOFIA requirements, that the Research Analyst’s analysis was made in good faith and that the views reflect the Research Analyst’s own opinion, without undue influence or intervention.

All authors named within this report are Research Analysts who produce independent research unless otherwise specified. In Europe, Sector Specialists (Sales and Trading) may be shown on this report as contacts but are not authors of the report or part of the Research Department.

Research excerpts: This material may include excerpts from previously published reports. For access to the full reports, including analyst certification and important disclosures, please contact your sales representative or the covering analyst’s team, or visit https://www.jpmorganmarkets.com.

Important Disclosures

  • Market Maker/ Liquidity Provider: J.P. Morgan is a market maker and/or liquidity provider in the financial instruments of/related to New York Community Bank.
  • Client: J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as clients: New York Community Bank.
  • Client/Non-Investment Banking, Securities-Related: J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as clients, and the services provided were non-investment-banking, securities-related: New York Community Bank.
  • Client/Non-Securities-Related: J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as clients, and the services provided were non-securities-related: New York Community Bank.
  • Potential Investment Banking Compensation: J.P. Morgan expects to receive, or intends to seek, compensation for investment banking services in the next three months from New York Community Bank.
  • Non-Investment Banking Compensation Received: J.P. Morgan has received compensation in the past 12 months for products or services other than investment banking from New York Community Bank.
  • Debt Position: J.P. Morgan may hold a position in the debt securities of New York Community Bank, if any.

Company-Specific Disclosures: Important disclosures, including price charts and credit opinion history tables, are available for compendium reports and all J.P. Morgan–covered companies, and certain non-covered companies, by visiting https://www.jpmm.com/research/disclosures, calling 1-800-477-0406, or e-mailing research.disclosure.inquiries@jpmorgan.com with your request.

Date Rating Price ($) Price Target ($)
01-Apr-21 N 12.62 13.5
27-Apr-21 N 12.53 14
25-Jun-21 N 11.22 13
29-Jul-21 N 12.06 14.5
28-Oct-21 N 12.82 14
15-Dec-21 N 11.88 13.5
01-Apr-22 N 10.72 12
28-Apr-22 N 9.80 11
04-Oct-22 N 8.87 10
13-Dec-22 N 8.69 9
01-Feb-23 N 9.99 9.5
21-Mar-23 N 8.61 10.5
06-Apr-23 N 8.76 9
02-May-23 N 10.71 11.5
29-Jun-23 N 11.19 13
28-Jul-23 OW 13.01 16
27-Oct-23 OW 9.87 15
05-Jan-24 OW 10.22 14
01-Feb-24 OW 6.47 11.5
07-Feb-24 N 4.20 5.5

The chart(s) show J.P. Morgan's continuing coverage of the stocks; the current analysts may or may not have covered it over the entire period. J.P. Morgan ratings or designations: OW = Overweight, N= Neutral, UW = Underweight, NR = Not Rated

Explanation of Equity Research Ratings, Designations and Analyst(s) Coverage Universe: J.P. Morgan uses the following rating system: Overweight (over the duration of the price target indicated in this report, we expect this stock will outperform the average total return of the stocks in the Research Analyst’s, or the Research Analyst’s team’s, coverage universe); Neutral (over the duration of the price target indicated in this report, we expect this stock will perform in line with the average total return of the stocks in the Research Analyst’s, or the Research Analyst’s team’s, coverage universe); and Underweight (over the duration of the price target indicated in this report, we expect this stock will underperform the average total return of the stocks in the Research Analyst’s, or the Research Analyst’s team’s, coverage universe. NR is Not Rated. In this case, J.P. Morgan has removed the rating and, if applicable, the price target, for this stock because of either a lack of a sufficient fundamental basis or for legal, regulatory or policy reasons. The previous rating and, if applicable, the price target, no longer should be relied upon. An NR designation is not a recommendation or a rating. In our Asia (ex-Australia and ex-India) and U.K. small- and mid-cap Equity Research, each stock’s expected total return is compared to the expected total return of a benchmark country market index, not to those Research Analysts’ coverage universe. If it does not appear in the Important Disclosures section of this report, the certifying Research Analyst’s coverage universe can be found on J.P. Morgan’s Research website, https://www.jpmorganmarkets.com.

J.P. Morgan Equity Research Ratings Distribution, as of January 01, 2024

Overweight(buy) Neutral(hold) Underweight(sell)
J.P. Morgan Global Equity Research Coverage* 47% 39% 13%
    IB clients** 48% 43% 32%
JPMS Equity Research Coverage* 46% 42% 12%
    IB clients** 68% 63% 46%

*Please note that the percentages may not add to 100% because of rounding.**Percentage of subject companies within each of the "buy," "hold" and "sell" categories for which J.P. Morgan has provided investment banking services within the previous 12 months. For purposes of FINRA ratings distribution rules only, our Overweight rating falls into a buy rating category; our Neutral rating falls into a hold rating category; and our Underweight rating falls into a sell rating category. Please note that stocks with an NR designation are not included in the table above. This information is current as of the end of the most recent calendar quarter.

Equity Valuation and Risks: For valuation methodology and risks associated with covered companies or price targets for covered companies, please see the most recent company-specific research report at http://www.jpmorganmarkets.com, contact the primary analyst or your J.P. Morgan representative, or email research.disclosure.inquiries@jpmorgan.com. For material information about the proprietary models used, please see the Summary of Financials in company-specific research reports and the Company Tearsheets, which are available to download on the company pages of our client website, http://www.jpmorganmarkets.com. This report also sets out within it the material underlying assumptions used.

A history of J.P. Morgan investment recommendations disseminated during the preceding 12 months can be accessed on the Research & Commentary page of http://www.jpmorganmarkets.com where you can also search by analyst name, sector or financial instrument.

Explanation of Emerging Markets Sovereign Research Ratings System and Valuation & Methodology: Ratings System : J.P. Morgan uses the following issuer portfolio weightings for Emerging Markets Sovereign Research: Overweight (over the next three months, the recommended risk position is expected to outperform the relevant index, sector, or benchmark credit returns); Marketweight (over the next three months, the recommended risk position is expected to perform in line with the relevant index, sector, or benchmark credit returns); and Underweight (over the next three months, the recommended risk position is expected to underperform the relevant index, sector, or benchmark credit returns). NR is Not Rated. In this case, J.P. Morgan has removed the rating for this security because of either legal, regulatory or policy reasons or because of lack of a sufficient fundamental basis. The previous rating no longer should be relied upon. An NR designation is not a recommendation or a rating. NC is Not Covered. An NC designation is not a rating or a recommendation. Recommendations will be at the issuer level, and an issuer recommendation applies to all of the index-eligible bonds at the same level for the issuer. When we change the issuer-level rating, we are changing the rating for all of the issues covered, unless otherwise specified. Ratings for quasi-sovereign issuers in the EMBIG may differ from the ratings provided in EM corporate coverage. Valuation & Methodology : For J.P. Morgan's Emerging Markets Sovereign Research, we assign a rating to each sovereign issuer (Overweight, Marketweight or Underweight) based on our view of whether the combination of the issuer’s fundamentals, market technicals, and the relative value of its securities will cause it to outperform, perform in line with, or underperform the credit returns of the EMBIGD index over the next three months. Our view of an issuer’s fundamentals includes our opinion of whether the issuer is becoming more or less able to service its debt obligations when they become due and payable, as well as whether its willingness to service debt obligations is increasing or decreasing.

J.P. Morgan Emerging Markets Sovereign Research Ratings Distribution, as of January 1, 2024

Overweight(buy) Marketweight(hold) Underweight(sell)
Global Sovereign Research Universe* 9% 83% 8%
    IB clients** 0% 47% 60%

*Please note that the percentages may not add to 100% because of rounding. **Percentage of subject issuers within each of the "Overweight, "Marketweight" and "Underweight" categories for which J.P. Morgan has provided investment banking services within the previous 12 months. For purposes of FINRA ratings distribution rules only, our Overweight rating falls into a buy rating category; our Marketweight rating falls into a hold rating category; and our Underweight rating falls into a sell rating category. The Emerging Markets Sovereign Research Rating Distribution is at the issuer level. Issuers with an NR or an NC designation are not included in the table above. This information is current as of the end of the most recent calendar quarter.

Explanation of Credit Research Valuation Methodology, Ratings and Risk to Ratings: J.P. Morgan uses a bond-level rating system that incorporates valuations (relative value) and our fundamental view on the security. Our fundamental credit view of an issuer is based on the company's underlying credit trends, overall creditworthiness and our opinion on whether the issuer will be able to service its debt obligations when they become due and payable. We analyze, among other things, the company's cash flow capacity and trends and standard credit ratios, such as gross and net leverage, interest coverage and liquidity ratios. We also analyze profitability, capitalization and asset quality, among other variables, when assessing financials. Analysts also rate the issuer, based on the rating of the benchmark or representative security. Unless we specify a different recommendation for the company’s individual securities, an issuer recommendation applies to all of the bonds at the same level of the issuer’s capital structure. We may also rate certain loans and preferred securities, as applicable. This report also sets out within it the material underlying assumptions used. We use the following ratings for bonds (issues), issuers, loans, and preferred securities: Overweight (over the next three months, the recommended risk position is expected to outperform the relevant index, sector, or benchmark); Neutral (over the next three months, the recommended risk position is expected to perform in line with the relevant index, sector, or benchmark); and Underweight (over the next three months, the recommended risk position is expected to underperform the relevant index, sector, or benchmark). J.P. Morgan Emerging Markets Sovereign Research uses Marketweight, which is equivalent to Neutral. NR is Not Rated. In this case, J.P. Morgan has removed the rating for this particular security or issuer because of either a lack of a sufficient fundamental basis or for legal, regulatory or policy reasons. The previous rating no longer should be relied upon. An NR designation is not a recommendation or a rating. NC is Not Covered. An NC designation is not a rating or a recommendation. For CDS, we use the following rating system: Long Risk (over the next three months, the credit return on the recommended position is expected to exceed the relevant index, sector or benchmark); Neutral (over the next three months, the credit return on the recommended position is expected to match the relevant index, sector or benchmark); and Short Risk (over the next three months, the credit return on the recommended position is expected to underperform the relevant index, sector or benchmark).

J.P. Morgan Credit Research Ratings Distribution, as of January 01, 2024

Overweight(buy) Neutral(hold) Underweight(sell)
Global Credit Research Universe* 27% 57% 16%
    IB clients** 62% 60% 62%

*Please note that the percentages may not add to 100% because of rounding.**Percentage of subject companies within each of the "Overweight," "Neutral" and "Underweight" categories for which J.P. Morgan has provided investment banking services within the previous 12 months.For purposes of FINRA ratings distribution rules only, our Overweight rating falls into a buy rating category; our Neutral rating falls into a hold rating category; and our Underweight rating falls into a sell rating category. The Credit Research Rating Distribution is at the issuer level. Issuers with an NR or an NC designation are not included in the table above. This information is current as of the end of the most recent calendar quarter.

Analysts' Compensation: The research analysts responsible for the preparation of this report receive compensation based upon various factors, including the quality and accuracy of research, client feedback, competitive factors, and overall firm revenues.

Registration of non-US Analysts: Unless otherwise noted, the non-US analysts listed on the front of this report are employees of non-US affiliates of J.P. Morgan Securities LLC, may not be registered as research analysts under FINRA rules, may not be associated persons of J.P. Morgan Securities LLC, and may not be subject to FINRA Rule 2241 or 2242 restrictions on communications with covered companies, public appearances, and trading securities held by a research analyst account.

Company-Specific Disclosures: Important disclosures, including price charts and credit opinion history tables, are available for compendium reports and all J.P. Morgan–covered companies, and certain non-covered companies, by visiting https://www.jpmm.com/research/disclosures, calling 1-800-477-0406, or e-mailing research.disclosure.inquiries@jpmorgan.com with your request.

Other Disclosures

J.P. Morgan is a marketing name for investment banking businesses of JPMorgan Chase & Co. and its subsidiaries and affiliates worldwide.

UK MIFID FICC research unbundling exemption: UK clients should refer to UK MIFID Research Unbundling exemption for details of J.P. Morgan’s implementation of the FICC research exemption and guidance on relevant FICC research categorisation.

QIB Only

All research material made available to clients are simultaneously available on our client website, J.P. Morgan Markets, unless specifically permitted by relevant laws. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research material available on a particular stock, please contact your sales representative.

Any long form nomenclature for references to China; Hong Kong; Taiwan; and Macau within this research material are Mainland China; Hong Kong SAR (China); Taiwan (China); and Macau SAR (China).

J.P. Morgan Research may, from time to time, write on issuers or securities targeted by economic or financial sanctions imposed or administered by the governmental authorities of the U.S., EU, UK or other relevant jurisdictions (Sanctioned Securities). Nothing in this report is intended to be read or construed as encouraging, facilitating, promoting or otherwise approving investment or dealing in such Sanctioned Securities. Clients should be aware of their own legal and compliance obligations when making investment decisions.

Any digital or crypto assets discussed in this research report are subject to a rapidly changing regulatory landscape. For relevant regulatory advisories on crypto assets, including bitcoin and ether, please see https://www.jpmorgan.com/disclosures/cryptoasset-disclosure.

The author(s) of this research report may not be licensed to carry on regulated activities in your jurisdiction and, if not licensed, do not hold themselves out as being able to do so.

Exchange-Traded Funds (ETFs): J.P. Morgan Securities LLC (“JPMS”) acts as authorized participant for substantially all U.S.-listed ETFs. To the extent that any ETFs are mentioned in this report, JPMS may earn commissions and transaction-based compensation in connection with the distribution of those ETF shares and may earn fees for performing other trade-related services, such as securities lending to short sellers of the ETF shares. JPMS may also perform services for the ETFs themselves, including acting as a broker or dealer to the ETFs. In addition, affiliates of JPMS may perform services for the ETFs, including trust, custodial, administration, lending, index calculation and/or maintenance and other services.

Options and Futures related research: If the information contained herein regards options- or futures-related research, such information is available only to persons who have received the proper options or futures risk disclosure documents. Please contact your J.P. Morgan Representative or visit https://www.theocc.com/components/docs/riskstoc.pdf for a copy of the Option Clearing Corporation's Characteristics and Risks of Standardized Options or http://www.finra.org/sites/default/files/Security_Futures_Risk_Disclosure_Statement_2018.pdf for a copy of the Security Futures Risk Disclosure Statement.

Changes to Interbank Offered Rates (IBORs) and other benchmark rates: Certain interest rate benchmarks are, or may in the future become, subject to ongoing international, national and other regulatory guidance, reform and proposals for reform. For more information, please consult: https://www.jpmorgan.com/global/disclosures/interbank_offered_rates

Private Bank Clients: Where you are receiving research as a client of the private banking businesses offered by JPMorgan Chase & Co. and its subsidiaries (“J.P. Morgan Private Bank”), research is provided to you by J.P. Morgan Private Bank and not by any other division of J.P. Morgan, including, but not limited to, the J.P. Morgan Corporate and Investment Bank and its Global Research division.

Legal entity responsible for the production and distribution of research: The legal entity identified below the name of the Reg AC Research Analyst who authored this material is the legal entity responsible for the production of this research. Where multiple Reg AC Research Analysts authored this material with different legal entities identified below their names, these legal entities are jointly responsible for the production of this research. Research Analysts from various J.P. Morgan affiliates may have contributed to the production of this material but may not be licensed to carry out regulated activities in your jurisdiction (and do not hold themselves out as being able to do so). Unless otherwise stated below, this material has been distributed by the legal entity responsible for production. If you have any queries, please contact the relevant Research Analyst in your jurisdiction or the entity in your jurisdiction that has distributed this research material.

Legal Entities Disclosures and Country-/Region-Specific Disclosures: Argentina: JPMorgan Chase Bank N.A Sucursal Buenos Aires is regulated by Banco Central de la República Argentina (“BCRA”- Central Bank of Argentina) and Comisión Nacional de Valores (“CNV”- Argentinian Securities Commission - ALYC y AN Integral N°51). Australia: J.P. Morgan Securities Australia Limited (“JPMSAL”) (ABN 61 003 245 234/AFS Licence No: 238066) is regulated by the Australian Securities and Investments Commission and is a Market Participant of ASX Limited, a Clearing and Settlement Participant of ASX Clear Pty Limited and a Clearing Participant of ASX Clear (Futures) Pty Limited. This material is issued and distributed in Australia by or on behalf of JPMSAL only to "wholesale clients" (as defined in section 761G of the Corporations Act 2001). A list of all financial products covered can be found by visiting https://www.jpmm.com/research/disclosures. J.P. Morgan seeks to cover companies of relevance to the domestic and international investor base across all Global Industry Classification Standard (GICS) sectors, as well as across a range of market capitalisation sizes. If applicable, in the course of conducting public side due diligence on the subject company(ies), the Research Analyst team may at times perform such diligence through corporate engagements such as site visits, discussions with company representatives, management presentations, etc. Research issued by JPMSAL has been prepared in accordance with J.P. Morgan Australia’s Research Independence Policy which can be found at the following link: J.P. Morgan Australia - Research Independence Policy. Brazil : Banco J.P. Morgan S.A. is regulated by the Comissao de Valores Mobiliarios (CVM) and by the Central Bank of Brazil. Ombudsman J.P. Morgan: 0800-7700847 / 0800-7700810 (For Hearing Impaired) / ouvidoria.jp.morgan@jpmorgan.com. Canada : J.P. Morgan Securities Canada Inc. is a registered investment dealer, regulated by the Canadian Investment Regulatory Organization and the Ontario Securities Commission and is the participating member on Canadian exchanges. This material is distributed in Canada by or on behalf of J.P.Morgan Securities Canada Inc. Chile: Inversiones J.P. Morgan Limitada is an unregulated entity incorporated in Chile. China: J.P. Morgan Securities (China) Company Limited has been approved by CSRC to conduct the securities investment consultancy business. Dubai International Financial Centre (DIFC) : JPMorgan Chase Bank, N.A., Dubai Branch is regulated by the Dubai Financial Services Authority (DFSA) and its registered address is Dubai International Financial Centre - The Gate, West Wing, Level 3 and 9 PO Box 506551, Dubai, UAE. This material has been distributed by JP Morgan Chase Bank, N.A., Dubai Branch to persons regarded as professional clients or market counterparties as defined under the DFSA rules. European Economic Area (EEA): Unless specified to the contrary, research is distributed in the EEA by J.P. Morgan SE (“JPM SE”), which is authorised as a credit institution by the Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht, BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB). JPM SE is a company headquartered in Frankfurt with registered address at TaunusTurm, Taunustor 1, Frankfurt am Main, 60310, Germany. The material has been distributed in the EEA to persons regarded as professional investors (or equivalent) pursuant to Art. 4 para. 1 no. 10 and Annex II of MiFID II and its respective implementation in their home jurisdictions (“EEA professional investors”). This material must not be acted on or relied on by persons who are not EEA professional investors. Any investment or investment activity to which this material relates is only available to EEA relevant persons and will be engaged in only with EEA relevant persons. Hong Kong : J.P. Morgan Securities (Asia Pacific) Limited (CE number AAJ321) is regulated by the Hong Kong Monetary Authority and the Securities and Futures Commission in Hong Kong, and J.P. Morgan Broking (Hong Kong) Limited (CE number AAB027) is regulated by the Securities and Futures Commission in Hong Kong. JP Morgan Chase Bank, N.A., Hong Kong Branch (CE Number AAL996) is regulated by the Hong Kong Monetary Authority and the Securities and Futures Commission, is organized under the laws of the United States with limited liability. Where the distribution of this material is a regulated activity in Hong Kong, the material is distributed in Hong Kong by or through J.P. Morgan Securities (Asia Pacific) Limited and/or J.P. Morgan Broking (Hong Kong) Limited. India : J.P. Morgan India Private Limited (Corporate Identity Number - U67120MH1992FTC068724), having its registered office at J.P. Morgan Tower, Off. C.S.T. Road, Kalina, Santacruz - East, Mumbai – 400098, is registered with the Securities and Exchange Board of India (SEBI) as a ‘Research Analyst’ having registration number INH000001873. J.P. Morgan India Private Limited is also registered with SEBI as a member of the National Stock Exchange of India Limited and the Bombay Stock Exchange Limited (SEBI Registration Number – INZ000239730) and as a Merchant Banker (SEBI Registration Number - MB/INM000002970). Telephone: 91-22-6157 3000, Facsimile: 91-22-6157 3990 and Website: http://www.jpmipl.com. JPMorgan Chase Bank, N.A. - Mumbai Branch is licensed by the Reserve Bank of India (RBI) (Licence No. 53/ Licence No. BY.4/94; SEBI - IN/CUS/014/ CDSL : IN-DP-CDSL-444-2008/ IN-DP-NSDL-285-2008/ INBI00000984/ INE231311239) as a Scheduled Commercial Bank in India, which is its primary license allowing it to carry on Banking business in India and other activities, which a Bank branch in India are permitted to undertake. For non-local research material, this material is not distributed in India by J.P. Morgan India Private Limited. Compliance Officer: Spurthi Gadamsetty; spurthi.gadamsetty@jpmchase.com; +912261573225. Grievance Officer: Ramprasadh K, jpmipl.research.feedback@jpmorgan.com; +912261573000.

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Indonesia : PT J.P. Morgan Sekuritas Indonesia is a member of the Indonesia Stock Exchange and is registered and supervised by the Otoritas Jasa Keuangan (OJK). Korea : J.P. Morgan Securities (Far East) Limited, Seoul Branch, is a member of the Korea Exchange (KRX). JPMorgan Chase Bank, N.A., Seoul Branch, is licensed as a branch office of foreign bank (JPMorgan Chase Bank, N.A.) in Korea. Both entities are regulated by the Financial Services Commission (FSC) and the Financial Supervisory Service (FSS). For non-macro research material, the material is distributed in Korea by or through J.P. Morgan Securities (Far East) Limited, Seoul Branch. Japan : JPMorgan Securities Japan Co., Ltd. and JPMorgan Chase Bank, N.A., Tokyo Branch are regulated by the Financial Services Agency in Japan. Malaysia : This material is issued and distributed in Malaysia by JPMorgan Securities (Malaysia) Sdn Bhd (18146-X), which is a Participating Organization of Bursa Malaysia Berhad and holds a Capital Markets Services License issued by the Securities Commission in Malaysia. Mexico : J.P. Morgan Casa de Bolsa, S.A. de C.V. and J.P. Morgan Grupo Financiero are members of the Mexican Stock Exchange and are authorized to act as a broker dealer by the National Banking and Securities Exchange Commission. New Zealand : This material is issued and distributed by JPMSAL in New Zealand only to "wholesale clients" (as defined in the Financial Markets Conduct Act 2013). JPMSAL is registered as a Financial Service Provider under the Financial Service providers (Registration and Dispute Resolution) Act of 2008. Philippines : J.P. Morgan Securities Philippines Inc. is a Trading Participant of the Philippine Stock Exchange and a member of the Securities Clearing Corporation of the Philippines and the Securities Investor Protection Fund. It is regulated by the Securities and Exchange Commission. Singapore : This material is issued and distributed in Singapore by or through J.P. Morgan Securities Singapore Private Limited (JPMSS) [MCI (P) 030/08/2023 and Co. Reg. No.: 199405335R], which is a member of the Singapore Exchange Securities Trading Limited, and/or JPMorgan Chase Bank, N.A., Singapore branch (JPMCB Singapore), both of which are regulated by the Monetary Authority of Singapore. This material is issued and distributed in Singapore only to accredited investors, expert investors and institutional investors, as defined in Section 4A of the Securities and Futures Act, Cap. 289 (SFA). This material is not intended to be issued or distributed to any retail investors or any other investors that do not fall into the classes of “accredited investors,” “expert investors” or “institutional investors,” as defined under Section 4A of the SFA. Recipients of this material in Singapore are to contact JPMSS or JPMCB Singapore in respect of any matters arising from, or in connection with, the material. South Africa : J.P. Morgan Equities South Africa Proprietary Limited and JPMorgan Chase Bank, N.A., Johannesburg Branch are members of the Johannesburg Securities Exchange and are regulated by the Financial Services Conduct Authority (FSCA). Taiwan : J.P. Morgan Securities (Taiwan) Limited is a participant of the Taiwan Stock Exchange (company-type) and regulated by the Taiwan Securities and Futures Bureau. Material relating to equity securities is issued and distributed in Taiwan by J.P. Morgan Securities (Taiwan) Limited, subject to the license scope and the applicable laws and the regulations in Taiwan. According to Paragraph 2, Article 7-1 of Operational Regulations Governing Securities Firms Recommending Trades in Securities to Customers (as amended or supplemented) and/or other applicable laws or regulations, please note that the recipient of this material is not permitted to engage in any activities in connection with the material that may give rise to conflicts of interests, unless otherwise disclosed in the “Important Disclosures” in this material. Thailand : This material is issued and distributed in Thailand by JPMorgan Securities (Thailand) Ltd., which is a member of the Stock Exchange of Thailand and is regulated by the Ministry of Finance and the Securities and Exchange Commission, and its registered address is 3rd Floor, 20 North Sathorn Road, Silom, Bangrak, Bangkok 10500. UK: Unless specified to the contrary, research is distributed in the UK by J.P. Morgan Securities plc (“JPMS plc”) which is a member of the London Stock Exchange and is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority. JPMS plc is registered in England & Wales No. 2711006, Registered Office 25 Bank Street, London, E14 5JP. This material is directed in the UK only to: (a) persons having professional experience in matters relating to investments falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) (Order) 2005 (“the FPO”); (b) persons outlined in article 49 of the FPO (high net worth companies, unincorporated associations or partnerships, the trustees of high value trusts, etc.); or (c) any persons to whom this communication may otherwise lawfully be made; all such persons being referred to as "UK relevant persons". This material must not be acted on or relied on by persons who are not UK relevant persons. Any investment or investment activity to which this material relates is only available to UK relevant persons and will be engaged in only with UK relevant persons. Research issued by JPMS plc has been prepared in accordance with JPMS plc's policy for prevention and avoidance of conflicts of interest related to the production of Research which can be found at the following link: J.P. Morgan EMEA - Research Independence Policy. U.S .: J.P. Morgan Securities LLC (“JPMS”) is a member of the NYSE, FINRA, SIPC, and the NFA. JPMorgan Chase Bank, N.A. is a member of the FDIC. Material published by non-U.S. affiliates is distributed in the U.S. by JPMS who accepts responsibility for its content.

General: Additional information is available upon request. The information in this material has been obtained from sources believed to be reliable. While all reasonable care has been taken to ensure that the facts stated in this material are accurate and that the forecasts, opinions and expectations contained herein are fair and reasonable, JPMorgan Chase & Co. or its affiliates and/or subsidiaries (collectively J.P. Morgan) make no representations or warranties whatsoever to the completeness or accuracy of the material provided, except with respect to any disclosures relative to J.P. Morgan and the Research Analyst's involvement with the issuer that is the subject of the material. Accordingly, no reliance should be placed on the accuracy, fairness or completeness of the information contained in this material. There may be certain discrepancies with data and/or limited content in this material as a result of calculations, adjustments, translations to different languages, and/or local regulatory restrictions, as applicable. These discrepancies should not impact the overall investment analysis, views and/or recommendations of the subject company(ies) that may be discussed in the material. J.P. Morgan accepts no liability whatsoever for any loss arising from any use of this material or its contents, and neither J.P. Morgan nor any of its respective directors, officers or employees, shall be in any way responsible for the contents hereof, apart from the liabilities and responsibilities that may be imposed on them by the relevant regulatory authority in the jurisdiction in question, or the regulatory regime thereunder. Opinions, forecasts or projections contained in this material represent J.P. Morgan's current opinions or judgment as of the date of the material only and are therefore subject to change without notice. Periodic updates may be provided on companies/industries based on company-specific developments or announcements, market conditions or any other publicly available information. There can be no assurance that future results or events will be consistent with any such opinions, forecasts or projections, which represent only one possible outcome. Furthermore, such opinions, forecasts or projections are subject to certain risks, uncertainties and assumptions that have not been verified, and future actual results or events could differ materially. The value of, or income from, any investments referred to in this material may fluctuate and/or be affected by changes in exchange rates. All pricing is indicative as of the close of market for the securities discussed, unless otherwise stated. Past performance is not indicative of future results. Accordingly, investors may receive back less than originally invested. This material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. The opinions and recommendations herein do not take into account individual client circumstances, objectives, or needs and are not intended as recommendations of particular securities, financial instruments or strategies to particular clients. This material may include views on structured securities, options, futures and other derivatives. These are complex instruments, may involve a high degree of risk and may be appropriate investments only for sophisticated investors who are capable of understanding and assuming the risks involved. The recipients of this material must make their own independent decisions regarding any securities or financial instruments mentioned herein and should seek advice from such independent financial, legal, tax or other adviser as they deem necessary. J.P. Morgan may trade as a principal on the basis of the Research Analysts’ views and research, and it may also engage in transactions for its own account or for its clients’ accounts in a manner inconsistent with the views taken in this material, and J.P. Morgan is under no obligation to ensure that such other communication is brought to the attention of any recipient of this material. Others within J.P. Morgan, including Strategists, Sales staff and other Research Analysts, may take views that are inconsistent with those taken in this material. Employees of J.P. Morgan not involved in the preparation of this material may have investments in the securities (or derivatives of such securities) mentioned in this material and may trade them in ways different from those discussed in this material. This material is not an advertisement for or marketing of any issuer, its products or services, or its securities in any jurisdiction.

Confidentiality and Security Notice : This transmission may contain information that is privileged, confidential, legally privileged, and/or exempt from disclosure under applicable law. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or use of the information contained herein (including any reliance thereon) is STRICTLY PROHIBITED. Although this transmission and any attachments are believed to be free of any virus or other defect that might affect any computer system into which it is received and opened, it is the responsibility of the recipient to ensure that it is virus free and no responsibility is accepted by JPMorgan Chase & Co., its subsidiaries and affiliates, as applicable, for any loss or damage arising in any way from its use. If you received this transmission in error, please immediately contact the sender and destroy the material in its entirety, whether in electronic or hard copy format. This message is subject to electronic monitoring: https://www.jpmorgan.com/disclosures/email

MSCI: Certain information herein (“Information”) is reproduced by permission of MSCI Inc., its affiliates and information providers (“MSCI”) ©2024. No reproduction or dissemination of the Information is permitted without an appropriate license. MSCI MAKES NO EXPRESS OR IMPLIED WARRANTIES (INCLUDING MERCHANTABILITY OR FITNESS) AS TO THE INFORMATION AND DISCLAIMS ALL LIABILITY TO THE EXTENT PERMITTED BY LAW. No Information constitutes investment advice, except for any applicable Information from MSCI ESG Research. Subject also to msci.com/disclaimer

"Other Disclosures" last revised February 03, 2024.

Copyright 2024 JPMorgan Chase & Co. All rights reserved. This material or any portion hereof may not be reprinted, sold or redistributed without the written consent of J.P. Morgan. It is strictly prohibited to use or share without prior written consent from J.P. Morgan any research material received from J.P. Morgan or an authorized third-party (“J.P. Morgan Data”) in any third-party artificial intelligence (“AI”) systems or models when such J.P. Morgan Data is accessible by a third-party. It is permissible to use J.P. Morgan Data for internal business purposes only in an AI system or model that protects the confidentiality of J.P. Morgan Data so as to prevent any and all access to or use of such J.P. Morgan Data by any third-party. #$J&098$#*P

Completed 04 Mar 2024 12:10 PM ESTDisseminated 04 Mar 2024 12:11 PM EST